Insiders Revium Rx.

Stocks

Market Closed - OTC Markets 10:43:00 2025-08-05 EDT			5-day change	1st Jan Change
0.5200 ^USD	+73.33%		-63.64%	-

08-13	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI

06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI
06-01	Revium Rx. Announces CFO Changes, Effective May 27, 2026	CI
04-20	Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026	CI
04-20	Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026	CI